Icagen to acquire Sanofi R&D site | Chemical & Engineering News
Volume 94 Issue 27 | p. 15 | Concentrates
Issue Date: July 4, 2016

Icagen to acquire Sanofi R&D site

Department: Business
Keywords: outsourcing, drug discovery, contract research, screening, R&D

Icagen, a drug discovery services firm, will acquire a Sanofi facility near Tucson, Ariz. The 26-year-old facility has its roots as a University of Arizona start-up and offers ultra-high-throughput biology, drug screening, and chemistry capabilities. Icagen will retain a majority of the scientists at the site, many with expertise in synthetic and computational chemistry and in rare disease biology and phenotypic screening. The deal includes a multiyear agreement for Icagen to supply discovery services to Sanofi and manage a Sanofi compound library.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment